A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans

[1]  W. Feng,et al.  The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains. , 2016, Canadian journal of microbiology.

[2]  L. See,et al.  Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[3]  Yinglong Hou,et al.  Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. , 2014, International journal of antimicrobial agents.

[4]  L. Andreassi,et al.  Non-infectious inflammatory genital lesions. , 2014, Clinics in dermatology.

[5]  E. Swoboda-Kopeć,et al.  Candida albicans morphologies revealed by scanning electron microscopy analysis , 2013, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[6]  D. Vaze,et al.  Devastating penile mycosis leading to penile gangrene. , 2013, Urology.

[7]  S. Kelly,et al.  Molecular Mechanisms of Drug Resistance in Clinical Candida Species Isolated from Tunisian Hospitals , 2013, Antimicrobial Agents and Chemotherapy.

[8]  Z. Salehi,et al.  Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz. , 2013, Journal of nephropathology.

[9]  L. Xi,et al.  A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy. , 2012, Medical mycology.

[10]  Zeng Zhong-ming.  Detection of minimum inhibitory concentration of 9 antifungal drugs to Candida albicans from Candidal balanoposthitis , 2011 .

[11]  F. Odds.  In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1. , 2009, FEMS yeast research.

[12]  Q. Ding,et al.  A case report of severe Aspergillus flavus penile infection. , 2009, Asian journal of andrology.

[13]  A. Rodrigues,et al.  Infectious balanoposthitis: management, clinical and laboratory features , 2009, International journal of dermatology.

[14]  M. Alsterholm,et al.  Frequency of bacteria, Candida and malassezia species in balanoposthitis. , 2008, Acta dermato-venereologica.

[15]  C. D. de Koster,et al.  The CRH Family Coding for Cell Wall Glycosylphosphatidylinositol Proteins with a Predicted Transglycosidase Domain Affects Cell Wall Organization and Virulence of Candida albicans* , 2006, Journal of Biological Chemistry.

[16]  J. Šubík,et al.  Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. , 2006, International journal of antimicrobial agents.

[17]  J. Lopez-Ribot,et al.  Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.

[18]  P. Mayser.  Mycotic infections of the penis , 1999, Andrologia.

[19]  C. Sonnex,et al.  Candidal balano-posthitis: a study of diagnostic methods. , 1995, Genitourinary medicine.

[20]  D. Kirsch,et al.  Isolation of the gene for cytochrome P450 L1A1 (lanosterol 14α-demethylase) from Candida albicans , 1988 .

[21]  D. Kirsch,et al.  Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. , 1988, Gene.